Audience Intelligence

Vertigo relief app

Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. is the first audience because the report already names a repeated pain, reachable channels, and a validation test that can be run before software is complete.

Segments

Who to validate first.

Start where pain, budget ownership, and reachable language overlap.

Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care.

BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositioning maneuvers like the Epley correctly at home from static diagrams. Without guided head-positioning, episode tracking, and recurrence coaching, patients self-treat incorrectly, relapse (recurrence occurs in roughly half of cases), and miss daily activities.

Trigger
BPPV is the most frequent vestibular disorder, with cumulative lifetime prevalence reported between 2.4% and 10%, higher in women (about 3.2% vs 1.6% in men) and rising with age, per population-based epidemiology studies indexed on NIH/PMC.
Budget
Freemium consumer subscription (core maneuver guides free; advanced tracking, history export, and reminders behind a monthly/annual plan) plus a B2B clinic tier where ENT/audiology/physio practices license the app for patient home programs.

Budget owner who feels the operational cost of the broken workflow.

Regulatory and medical-claims risk: positioning the app as treating or curing BPPV can trigger FDA software-as-a-medical-device scrutiny and liability; marketing must stay within wellness/educational claims and carry medical disclaimers.

Trigger
AI-assisted product work and managed infrastructure reduce the first-version cost.
Budget
$49-$499/month

Hands-on operator willing to pilot a narrow tool before a full rollout.

Clinical safety risk: the Epley maneuver is unsafe for some users (neck/back disease, vascular conditions, retinal detachment) and self-diagnosis may miss serious causes of vertigo such as stroke, so robust screening and escalation prompts are essential.

Trigger
Freemium consumer subscription (core maneuver guides free; advanced tracking, history export, and reminders behind a monthly/annual plan) plus a B2B clinic tier where ENT/audiology/physio practices license the app for patient home programs.
Budget
$99-$1,000/year add-on

Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. who still run the workflow in spreadsheets, generic docs, email, or chat threads.

BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositioning maneuvers like the Epley correctly at home from static diagrams. Without guided head-positioning, episode tracking, and recurrence coaching, patients self-treat incorrectly, relapse (recurrence occurs in roughly half of cases), and miss daily activities.

Trigger
The wedge is specific enough to test without claiming the whole market.
Budget
Custom

Channels

Where the audience can be found.

Use these lanes for complaint mining, interviews, and concierge pilot offers.

Reddit / forums

Look for complaints, workarounds, and repeated questions.

First move: Post a problem teardown for Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space. and ask how people solve it today.

Launch communities

Launch traction shows whether the promise is legible.

First move: Ship a narrow demo and watch which promise gets clicks.

Review and alternative pages

Pricing and alternatives expose buyer objections.

First move: Write an alternatives page that owns one narrow use case.

Community pain posts

Use communities and forums where Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. already describe the painful workflow.

First move: Problem teardown, interview ask, and short demo clip

Direct outreach

Direct conversations are the fastest way to verify budget ownership and switching cost.

First move: Concierge pilot offer with a manually prepared sample

Intent keywords

vertigo workflowrelief validationvertigo airelief automationdigital-healthvestibularBPPVtelehealthmobile-appConsumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space.

Messaging angles

  • Vertigo relief app should be tested as a narrow first-win workflow for Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care..
  • Replace a narrow workflow that reaches value without configuration-heavy onboarding. with a focused first-win workflow.
  • Promise proof around problem resonance: 5+ calls or 10+ detailed replies..
  • De-risk adoption with concierge review or paid template.

Likely objections

  • Regulatory and medical-claims risk: positioning the app as treating or curing BPPV can trigger FDA software-as-a-medical-device scrutiny and liability; marketing must stay within wellness/educational claims and carry medical disclaimers.
  • Clinical safety risk: the Epley maneuver is unsafe for some users (neck/back disease, vascular conditions, retinal detachment) and self-diagnosis may miss serious causes of vertigo such as stroke, so robust screening and escalation prompts are essential.
  • Crowded niche with several established free and low-cost competitors and inherently low willingness-to-pay for an episodic, often self-resolving condition, making retention and recurring revenue difficult.
  • Needs real buyer access, not only desk research.
  • Needs proof of budget or repeated urgency.
  • Needs a crisp wedge before broad product work starts.

Research handoff

Use this audience profile to recruit interviews, draft comparison pages, and ground ad creative before building beyond the first workflow.